impact of glp-1 drugs on industries FDA's compounded limits will have ripple effects throughout the retail industry GLP-1 Drugs Market Size to

The magnitude of the benefits of GLP-1RA and SGLT-2 inhibitors on MACE are similar, ranging from 12 to 14% reduction of risk, but only GLP-1RA may reduce the risk of stroke

### Funding Statement SDL and AC were supported by the National Science Foundation (Grant Nos.\ CAREER DMS-1944574 and DMS-2325258) ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained

RESET YOUR WEIGHT

Explore the intersection of GLP-1 therapies and gut health to manage metabolic dysfunction and support patient wellness.

This article examines clinical safety data, GI mechanisms, and how genetic predispositions may influence medication tolerance in IBD patients see